Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hannah A. Staley"'
Autor:
Hannah A. Staley, Janna E. Jernigan, MacKenzie L. Bolen, Ann M. Titus, Noelle Neighbarger, Cassandra Cole, Kelly B. Menees, Rebecca L. Wallings, Malú Gámez Tansey
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-16 (2024)
Abstract Genome-wide association studies have identified a protective mutation in the phospholipase C gamma 2 (PLCG2) gene which confers protection against Alzheimer’s disease (AD)-associated cognitive decline. Therefore, PLCG2, which is primarily
Externí odkaz:
https://doaj.org/article/2fe3c49932fc460e96040f55471113e1
Autor:
Rebecca L. Wallings, Laura P. Hughes, Hannah A. Staley, Zachary D. Simon, Nikolaus R. McFarland, Roy N. Alcalay, Alicia Garrido, María José Martí, Eduardo Tolosa Sarró, Nicolas Dzamko, Malú Gámez Tansey
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 16 (2022)
Both leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GCase) are promising targets for the treatment of Parkinson’s disease (PD). Evidence suggests that both proteins are involved in biological pathways involving the lysosome. However,
Externí odkaz:
https://doaj.org/article/b43410a08f0b43d2a8bc37fb45f77375
Autor:
Valerie Joers, Benjamin C Murray, Caroline McLaughlin, Danielle Oliver, Hannah E. Staley, Jazmyn Coronado, Cindy Achat-Mendes, Sanam Golshani, Sean D. Kelly, Matthew Goodson, Danica Lee, Fredric P. Manfredsson, Bob M. Moore II, Malú Gámez Tansey
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-20 (2024)
Abstract Research into the disequilibrium of microglial phenotypes has become an area of intense focus in neurodegenerative disease as a potential mechanism that contributes to chronic neuroinflammation and neuronal loss in Parkinson’s disease (PD)
Externí odkaz:
https://doaj.org/article/dae8f1cd186941429aefb572745115d0